A Single-Dose Study to Examine the Within Subject Variability of Clexane (80 mg) s.c. in Healthy Adult Subjects Under Fasting Conditions

Trial Profile

A Single-Dose Study to Examine the Within Subject Variability of Clexane (80 mg) s.c. in Healthy Adult Subjects Under Fasting Conditions

Completed
Phase of Trial: Phase I

Latest Information Update: 26 Apr 2014

At a glance

  • Drugs Enoxaparin sodium (Primary)
  • Indications Deep vein thrombosis; Embolism; Myocardial infarction; Thromboembolism; Thrombosis; Unstable angina pectoris
  • Focus Pharmacokinetics
  • Most Recent Events

    • 26 Apr 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top